Multicenter Intravascular Ultrasound (IVUS) Validation Study Among Heart Transplant Recipients: Outcomes After 5 Years. J Am College of Cardiology 2005;45(9):1532-1537. Daclizumab is associated with decreased rejection and no increased mortality in cardiac transplant patients receiving MMF, cyclosporine and corticosteroids. Transplant Proc 2005;37:1333-39. Improving outcomes in heart transplantation - the potential of proliferation signal inhibitors. Transplant Proc 2005;37(4 Suppl):4-17. The economic implication of noninvasive molecular testing for cardiac allograft rejection. Am J Transplant 2005;5:1553-1558. Three-year results of a randomized, double-blind, controlled trial of mycophenolate mofetil versus azathioprine in cardiac transplant recipients. J Heart Lung Transplant. 2005;24(5):517-25. Immunosuppressants in cardiac transplantation. Hosp Pharm Europe 2005 May/June. Predictors of Quality of Life at 5 to 6 Years After Heart Transplantation. J Heart Lung Transplant 2005. 2005 Sep;24(9):1431-9. Physical Activity Patterns in Heart Transplant Women. J Cardiovasc Nurs. 2005 September/October;20(5):334-339. Review of major clinical trials with mycophenolate mofetil in cardiac transplantation. Transplantation. 2005 Oct 15;80(2 Suppl):S235-43. Ten-Year Follow-up of a Randomized Trial of Pravastatin in Heart Transplant Patients. J Heart Lung Transplant 2005. Nov;24(11):1736-1740. Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant. 2005 Nov;24(11):1710-20. Editorial: The revised ISHLT Heart Biopsy Grading Scale. J Heart Lung Transplant 2005. J Heart Lung Transplant. 2005 Nov;24(11):1709. Predictors of physical functional disability at 5-6 years after heart transplantation. J Heart Lung Transplant 2005 Dec;24(12):2279-85. Noninvasive discrimination of rejection in cardiac allograft recipients using gene expression profiling. Am J Transplant. 2006 Jan;6(1):150-60. Acute Antibody-mediated Rejection of Cardiac Transplants. J Heart Lung Transplant. 2006 Feb;25(2):153-159. Perioperative Renal Function and Outcome after Orthotopic Heart Transplantation. J Heart Lung Transplant. 2006 Feb;25(2):162-66. Should we be doing routine biopsy after heart transplantation in a new era of anti-rejection? Curr Opin Cardiol. 2006 Mar;21(2):127-31. Review: Immunosuppression for heart transplantation: where are we now? Nat Clin Pract Cardiovasc Med. 2006;3(4):203-12. Five-Year Results of a Randomized Single Center Study of Tacrolimus Versus Micoremulsion Cyclosporine in Heart Transplant Patients. J Heart and Lung Transplant 2006;25(4):434-9. Task force I: Revisiting listing criteria for heart transplantation. J Heart Lung Transplant 2005. Mycophenolate mofetil reduces intimal thickness by intravascular ultrasound after heart transplantation: reanalysis of the multicenter trial. Am J Transplant 2006 Tacrolimus with mycophenolate mofetil (MMF) or sirolimus vs. cyclosporine with MMF in cardiac transplant patients: 1-year report.. Am J Transplant 2006 Usefulness and Safety of Percutaneous Coronary Interventions for Cardiac Transplant Vasculopathy. Am J Cardiol. 2006 Everolimus: A Review. Exp Opin Pharmac. 2006 Vascular remodelling after cardiac transplantation: a 3-year serial intravascular ultrasound study.
